Clinical Investigation of AcrySof® IQ PanOptix™ IOL Model TFNT00
Public ClinicalTrials.gov record NCT03280108. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this clinical study is to compare the visual outcomes of the AcrySof IQ PanOptix Multifocal Intraocular Lens (IOL) Model TFNT00 against that of a monofocal lens, the AcrySof Monofocal IOL Model SN60AT, in order to demonstrate comparable distance vision and superior near and intermediate vision.
Study identification
- NCT ID
- NCT03280108
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 250 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 22 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 1, 2017 (Actual)
- Primary completion
- Sep 27, 2018 (Actual)
- Completion
- Sep 27, 2018 (Actual)
- Last update posted
- Oct 10, 2019
2017 – 2018
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alcon Investigative Site | Fresno | California | 93720 | — |
| Alcon Investigative Site | Mt. Dora | Florida | 32757 | — |
| Alcon Investigative Site | Panama City | Florida | 32405 | — |
| Alcon Investigative Site | Poughkeepsie | New York | 12603 | — |
| Alcon Investigative Site | Mt. Pleasant | South Carolina | 29464 | — |
| Alcon Investigative Site | Sioux Falls | South Dakota | 57108 | — |
| Alcon Investigative Site | Nashville | Tennessee | 37205 | — |
| Alcon Investigative Site | Houston | Texas | 77027 | — |
| Alcon Investigative Site | Hurst | Texas | 76054 | — |
| Alcon Investigative Site | Nacogdoches | Texas | 75965 | — |
| Alcon Investigative Site | Salt Lake City | Utah | 84107 | — |
| Alcon Investigative Site | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03280108, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 10, 2019 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03280108 live on ClinicalTrials.gov.